Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation | Zendy

Catherine J. Mercaldi | Zendy; Mike Ciarametaro | Zendy; Beth Hahn | Zendy; George Chalissery | Zendy; Matthew W. Reynolds | Zendy; Stephen Sander | Zendy; Gregory P. Samsa | Zendy; David B. Matchar | Zendy

Open Access

Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation

Author(s) -

Catherine J. Mercaldi,

Mike Ciarametaro,

Beth Hahn,

George Chalissery,

Matthew W. Reynolds,

Stephen Sander,

Gregory P. Samsa,

David B. Matchar

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.592907

Subject(s) - medicine , warfarin , atrial fibrillation , stroke (engine) , incidence (geometry) , proportional hazards model , bleed , emergency medicine , medicaid , cardiology , surgery , health care , mechanical engineering , physics , optics , engineering , economics , economic growth

in controlled trials, anticoagulation with warfarin reduces stroke risk by nearly two thirds, but the benefit has been less pronounced in clinical practice. This report describes the extent of warfarin use, its effectiveness, and its impact on medical costs among Medicare patients with nonvalvular atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research